November 2019
MRI-targeted biopsy: attractive and reliable diagnostic strategy for prostate cancer
Two great papers, recently published in European Urology, confirm that MRI-targeted biopsy is the attractive and reliable diagnostic strategy for prostate cancer compared to the traditional diagnostic pathway of systematic TRUS biopsy.
Read more
October 2019
New strong clinical data for Sonablate HIFU
New strong clinical data for Sonablate HIFU, recently published in the BJU International, confirms very promising medium-term oncological outcomes.
Read more
June 2019
An excellent presentation about Targeted Biopsy and Focal HIFU Therapy Program by UCLA group
At the AUA congress in Chicago, Prof. Leonard Marks and the UCLA group presented a method for focal HIFU, employing multiparametric magnetic resonance imaging, fusion biopsy, margin generation, and targeted treatment.
Read more
May 2019
The newest generation single-use flexible ureteroscope has arrived
We are delighted to announce a new partnership with OTU Medical Inc., a Silicon Valley based medical technology company, which recently received the EU approval for its second generation WiScope® single-use flexible digital ureteroscope.
Read more
February 2019
Prostate Imaging and Focal Therapy Masterclass at Imperial College London
We’re pleased to announce that the Prostate Imaging and Focal Therapy Masterclass, presented by one of the world’s leading urologists and experts in focal therapy, Prof. Hashim Ahmed, Chair of Urology of Imperial College London, will be returning on the 5-6th April 2019 for its second event.
Read more
January 2019
SonoIQ - a small pocket ultrasound to go
SonoIQ, a small pocket Ultrasound, transfers high resolution ultrasound images to Android, iOS or Windows smartphone or tablet via WiFi or USB cable.
Read more
November 2018
New study about Gold Anchor confirms low risk of infection and great marker stability
We are happy to share with you a new study about Gold Anchor from the Karolinska University Hospital in Stockholm, Sweden.
Conclusion of the study: The use of thin needles for the implantation of fiducials appears to reduce the rate of infection despite the use of a single dose of non-broad-spectrum antibiotics as prophylaxis. The marker construct appears to provide stability in the tissues.
Read more
September 2018
Strong Clinical Data for Sonablate HIFU
The UK urologist group led by University College and Imperial College London published 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients.
Read more
We take our time with you
We look forward to getting in touch with you
Thank you for your inquiry. We will answer you as soon as possible.
This site uses cookies to improve your user experience. You may find out more about in our Privacy Policy. By using this website you accept our use of cookies.